Coherus Biosciences (8C5) Ownership - Who Owns Coherus Biosciences?
2 Followers
Coherus Biosciences (8C5) Ownership Overview
- 1.24% Insiders
- 10.41% Mutual Funds
- 8.74% Other Institutional Investors
- 8.45% ETFs
- 71.17% Public Companies and Individual Investors
The ownership structure of Coherus Biosciences (DE:8C5) stock is a mix of institutional, retail, and individual investors. Approximately 27.60% of the company’s stock is owned by Institutional Investors, 1.24% is owned by Insiders, and 71.17% is owned by Public Companies and Individual Investors.
The ownership structure of Coherus Biosciences (DE:8C5) stock is a mix of institutional, retail, and individual investors. Approximately 27.60% of the company’s stock is owned by Institutional Investors, 1.24% is owned by Insiders, and 71.17% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 12,003,316 | Institution | 7.77% | 9,902,736 |
| Vanguard | 6,300,361 | Institution | 4.08% | 5,197,798 |
| Vanguard Index Funds | 5,817,206 | Institution | 3.77% | 4,799,195 |
| Ishares | 5,005,984 | Institution | 3.24% | 4,129,937 |
| Delaware Group Equity Funds Iv | 2,700,000 | Institution | 1.75% | 2,227,500 |
| Fidelity Salem Street Trust | 1,607,367 | Institution | 1.04% | 1,326,078 |
| Dennis Lanfear | 1,567,884 | Insider | 1.01% | 1,293,504 |
| Fidelity Concord Street Trust | 1,509,314 | Institution | 0.98% | 1,245,184 |
| Blackrock Funds | 1,130,901 | Institution | 0.73% | 932,993 |
| Vanguard Scottsdale Funds | 885,185 | Institution | 0.57% | 730,278 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 5,817,206 | Institution | 3.77% | 4,799,195 |
| Delaware Group Equity Funds Iv | 2,700,000 | Institution | 1.75% | 2,227,500 |
| Fidelity Salem Street Trust | 1,607,367 | Institution | 1.04% | 1,326,078 |
| Fidelity Concord Street Trust | 1,509,314 | Institution | 0.98% | 1,245,184 |
| Blackrock Funds | 1,130,901 | Institution | 0.73% | 932,993 |
| Vanguard Scottsdale Funds | 885,185 | Institution | 0.57% | 730,278 |
| Schwab Capital Trust | 427,606 | Institution | 0.28% | 352,775 |
| Bridgeway Funds, Inc. | 391,000 | Institution | 0.25% | 322,575 |
| Mutual Fund Series Trust | 330,000 | Institution | 0.21% | 272,250 |
| Tiaa-cref Funds | 269,176 | Institution | 0.17% | 222,070 |
FAQ
Who Owns Coherus Biosciences (DE:8C5)?
According to the latest TipRanks data, approximately 27.60% of the company's stock is held by institutional investors, 1.24% is held by insiders, and 71.17% is held by public companies and individual investors.
What percentage of Coherus Biosciences (DE:8C5) stock is held by institutional investors?
According to the latest TipRanks data, approximately 27.60% of Coherus Biosciences (DE:8C5) stock is held by institutional investors: 10.41% by mutual funds, 8.45% by ETFs and 8.74% by other institutional investors.
What percentage of Coherus Biosciences (DE:8C5) stock is held by retail investors?
According to the latest TipRanks data, approximately 71.17% of Coherus Biosciences (DE:8C5) stock is held by public companies and individual investors.
Who owns the most shares of Coherus Biosciences (DE:8C5)?
BlackRock, Inc. owns the most shares of Coherus Biosciences (DE:8C5).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
